ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Miscellaneous Antimalarials Market Research Report 2025
Published Date: June 2025
|
Report Code: QYRE-Auto-36K5742
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Miscellaneous Antimalarials Market Insights Forecast to 2028
BUY CHAPTERS

Global Miscellaneous Antimalarials Market Research Report 2025

Code: QYRE-Auto-36K5742
Report
June 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Norvatis
Teva Pharmaceutical Industries
Bayer
GlaxoSmithKline PLC
Ipca Laboratories Ltd
Milan Pharmaceuticals
Paso Laboratories
Glenmark Pharmaceutical Inc.
Zydus Cadila

Miscellaneous Antimalarials Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Miscellaneous Antimalarials Market

Miscellaneous Antimalarials Market

The global market for Miscellaneous Antimalarials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Misecellaneous antimalarials are drugs effective in the treatment of malaria. Malaria is an infectious disease caused by the bite of an anopheles mosquito infected with certain protozoans. The best way to prevent malaria is by taking antimalarial drugs prophylactically prior to entering an endemic area.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Miscellaneous Antimalarials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Miscellaneous Antimalarials.
The Miscellaneous Antimalarials market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Miscellaneous Antimalarials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Miscellaneous Antimalarials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Miscellaneous Antimalarials Market Report

Report Metric Details
Report Name Miscellaneous Antimalarials Market
CAGR 5%
Segment by Type
  • Doxycyline
  • Pyrimethamine
  • Halofantrine
Segment by Application
  • Prevention
  • Treatment
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Norvatis, Teva Pharmaceutical Industries, Bayer AG., GlaxoSmithKline Plc., Ipca Laboratories Ltd., Milan Pharmaceuticals, Paso Laboratories, Glenmark Pharmaceutical Inc., Zydus Cadila
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Miscellaneous Antimalarials manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Miscellaneous Antimalarials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Miscellaneous Antimalarials Market report?

Ans: The main players in the Miscellaneous Antimalarials Market are Norvatis, Teva Pharmaceutical Industries, Bayer AG., GlaxoSmithKline Plc., Ipca Laboratories Ltd., Milan Pharmaceuticals, Paso Laboratories, Glenmark Pharmaceutical Inc., Zydus Cadila

What are the Application segmentation covered in the Miscellaneous Antimalarials Market report?

Ans: The Applications covered in the Miscellaneous Antimalarials Market report are Prevention, Treatment

What are the Type segmentation covered in the Miscellaneous Antimalarials Market report?

Ans: The Types covered in the Miscellaneous Antimalarials Market report are Doxycyline, Pyrimethamine, Halofantrine

1 Miscellaneous Antimalarials Market Overview
1.1 Product Definition
1.2 Miscellaneous Antimalarials by Type
1.2.1 Global Miscellaneous Antimalarials Market Value Comparison by Type (2024 VS 2031)
1.2.2 Doxycyline
1.2.3 Pyrimethamine
1.2.4 Halofantrine
1.3 Miscellaneous Antimalarials by Application
1.3.1 Global Miscellaneous Antimalarials Market Value by Application (2024 VS 2031)
1.3.2 Prevention
1.3.3 Treatment
1.4 Global Miscellaneous Antimalarials Market Size Estimates and Forecasts
1.4.1 Global Miscellaneous Antimalarials Revenue 2020-2031
1.4.2 Global Miscellaneous Antimalarials Sales 2020-2031
1.4.3 Global Miscellaneous Antimalarials Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Miscellaneous Antimalarials Market Competition by Manufacturers
2.1 Global Miscellaneous Antimalarials Sales Market Share by Manufacturers (2020-2025)
2.2 Global Miscellaneous Antimalarials Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Miscellaneous Antimalarials Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Miscellaneous Antimalarials, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Miscellaneous Antimalarials, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Miscellaneous Antimalarials, Product Type & Application
2.7 Global Key Manufacturers of Miscellaneous Antimalarials, Date of Enter into This Industry
2.8 Global Miscellaneous Antimalarials Market Competitive Situation and Trends
2.8.1 Global Miscellaneous Antimalarials Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Miscellaneous Antimalarials Players Market Share by Revenue
2.8.3 Global Miscellaneous Antimalarials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Miscellaneous Antimalarials Market Scenario by Region
3.1 Global Miscellaneous Antimalarials Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Miscellaneous Antimalarials Sales by Region: 2020-2031
3.2.1 Global Miscellaneous Antimalarials Sales by Region: 2020-2025
3.2.2 Global Miscellaneous Antimalarials Sales by Region: 2026-2031
3.3 Global Miscellaneous Antimalarials Revenue by Region: 2020-2031
3.3.1 Global Miscellaneous Antimalarials Revenue by Region: 2020-2025
3.3.2 Global Miscellaneous Antimalarials Revenue by Region: 2026-2031
3.4 North America Miscellaneous Antimalarials Market Facts & Figures by Country
3.4.1 North America Miscellaneous Antimalarials Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Miscellaneous Antimalarials Sales by Country (2020-2031)
3.4.3 North America Miscellaneous Antimalarials Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Miscellaneous Antimalarials Market Facts & Figures by Country
3.5.1 Europe Miscellaneous Antimalarials Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Miscellaneous Antimalarials Sales by Country (2020-2031)
3.5.3 Europe Miscellaneous Antimalarials Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Miscellaneous Antimalarials Market Facts & Figures by Region
3.6.1 Asia Pacific Miscellaneous Antimalarials Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Miscellaneous Antimalarials Sales by Region (2020-2031)
3.6.3 Asia Pacific Miscellaneous Antimalarials Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Miscellaneous Antimalarials Market Facts & Figures by Country
3.7.1 Latin America Miscellaneous Antimalarials Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Miscellaneous Antimalarials Sales by Country (2020-2031)
3.7.3 Latin America Miscellaneous Antimalarials Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Miscellaneous Antimalarials Market Facts & Figures by Country
3.8.1 Middle East and Africa Miscellaneous Antimalarials Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Miscellaneous Antimalarials Sales by Country (2020-2031)
3.8.3 Middle East and Africa Miscellaneous Antimalarials Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Miscellaneous Antimalarials Sales by Type (2020-2031)
4.1.1 Global Miscellaneous Antimalarials Sales by Type (2020-2025)
4.1.2 Global Miscellaneous Antimalarials Sales by Type (2026-2031)
4.1.3 Global Miscellaneous Antimalarials Sales Market Share by Type (2020-2031)
4.2 Global Miscellaneous Antimalarials Revenue by Type (2020-2031)
4.2.1 Global Miscellaneous Antimalarials Revenue by Type (2020-2025)
4.2.2 Global Miscellaneous Antimalarials Revenue by Type (2026-2031)
4.2.3 Global Miscellaneous Antimalarials Revenue Market Share by Type (2020-2031)
4.3 Global Miscellaneous Antimalarials Price by Type (2020-2031)
5 Segment by Application
5.1 Global Miscellaneous Antimalarials Sales by Application (2020-2031)
5.1.1 Global Miscellaneous Antimalarials Sales by Application (2020-2025)
5.1.2 Global Miscellaneous Antimalarials Sales by Application (2026-2031)
5.1.3 Global Miscellaneous Antimalarials Sales Market Share by Application (2020-2031)
5.2 Global Miscellaneous Antimalarials Revenue by Application (2020-2031)
5.2.1 Global Miscellaneous Antimalarials Revenue by Application (2020-2025)
5.2.2 Global Miscellaneous Antimalarials Revenue by Application (2026-2031)
5.2.3 Global Miscellaneous Antimalarials Revenue Market Share by Application (2020-2031)
5.3 Global Miscellaneous Antimalarials Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Norvatis
6.1.1 Norvatis Company Information
6.1.2 Norvatis Description and Business Overview
6.1.3 Norvatis Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Norvatis Miscellaneous Antimalarials Product Portfolio
6.1.5 Norvatis Recent Developments/Updates
6.2 Teva Pharmaceutical Industries
6.2.1 Teva Pharmaceutical Industries Company Information
6.2.2 Teva Pharmaceutical Industries Description and Business Overview
6.2.3 Teva Pharmaceutical Industries Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceutical Industries Miscellaneous Antimalarials Product Portfolio
6.2.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.3 Bayer AG.
6.3.1 Bayer AG. Company Information
6.3.2 Bayer AG. Description and Business Overview
6.3.3 Bayer AG. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Bayer AG. Miscellaneous Antimalarials Product Portfolio
6.3.5 Bayer AG. Recent Developments/Updates
6.4 GlaxoSmithKline Plc.
6.4.1 GlaxoSmithKline Plc. Company Information
6.4.2 GlaxoSmithKline Plc. Description and Business Overview
6.4.3 GlaxoSmithKline Plc. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.4.4 GlaxoSmithKline Plc. Miscellaneous Antimalarials Product Portfolio
6.4.5 GlaxoSmithKline Plc. Recent Developments/Updates
6.5 Ipca Laboratories Ltd.
6.5.1 Ipca Laboratories Ltd. Company Information
6.5.2 Ipca Laboratories Ltd. Description and Business Overview
6.5.3 Ipca Laboratories Ltd. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Ipca Laboratories Ltd. Miscellaneous Antimalarials Product Portfolio
6.5.5 Ipca Laboratories Ltd. Recent Developments/Updates
6.6 Milan Pharmaceuticals
6.6.1 Milan Pharmaceuticals Company Information
6.6.2 Milan Pharmaceuticals Description and Business Overview
6.6.3 Milan Pharmaceuticals Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Milan Pharmaceuticals Miscellaneous Antimalarials Product Portfolio
6.6.5 Milan Pharmaceuticals Recent Developments/Updates
6.7 Paso Laboratories
6.7.1 Paso Laboratories Company Information
6.7.2 Paso Laboratories Description and Business Overview
6.7.3 Paso Laboratories Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Paso Laboratories Miscellaneous Antimalarials Product Portfolio
6.7.5 Paso Laboratories Recent Developments/Updates
6.8 Glenmark Pharmaceutical Inc.
6.8.1 Glenmark Pharmaceutical Inc. Company Information
6.8.2 Glenmark Pharmaceutical Inc. Description and Business Overview
6.8.3 Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Product Portfolio
6.8.5 Glenmark Pharmaceutical Inc. Recent Developments/Updates
6.9 Zydus Cadila
6.9.1 Zydus Cadila Company Information
6.9.2 Zydus Cadila Description and Business Overview
6.9.3 Zydus Cadila Miscellaneous Antimalarials Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zydus Cadila Miscellaneous Antimalarials Product Portfolio
6.9.5 Zydus Cadila Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Miscellaneous Antimalarials Industry Chain Analysis
7.2 Miscellaneous Antimalarials Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Miscellaneous Antimalarials Production Mode & Process Analysis
7.4 Miscellaneous Antimalarials Sales and Marketing
7.4.1 Miscellaneous Antimalarials Sales Channels
7.4.2 Miscellaneous Antimalarials Distributors
7.5 Miscellaneous Antimalarials Customer Analysis
8 Miscellaneous Antimalarials Market Dynamics
8.1 Miscellaneous Antimalarials Industry Trends
8.2 Miscellaneous Antimalarials Market Drivers
8.3 Miscellaneous Antimalarials Market Challenges
8.4 Miscellaneous Antimalarials Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Norvatis
Teva Pharmaceutical Industries
Bayer
GlaxoSmithKline PLC
Ipca Laboratories Ltd
Milan Pharmaceuticals
Paso Laboratories
Glenmark Pharmaceutical Inc.
Zydus Cadila
List of Tables
 Table 1. Global Miscellaneous Antimalarials Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Miscellaneous Antimalarials Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Miscellaneous Antimalarials Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Miscellaneous Antimalarials Sales (Tons) of Key Manufacturers (2020-2025)
 Table 5. Global Miscellaneous Antimalarials Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Miscellaneous Antimalarials Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Miscellaneous Antimalarials Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Miscellaneous Antimalarials Average Price (US$/Kg) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Miscellaneous Antimalarials, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Miscellaneous Antimalarials, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Miscellaneous Antimalarials, Product Type & Application
 Table 12. Global Key Manufacturers of Miscellaneous Antimalarials, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Miscellaneous Antimalarials by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Miscellaneous Antimalarials as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Miscellaneous Antimalarials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Miscellaneous Antimalarials Sales by Region (2020-2025) & (Tons)
 Table 18. Global Miscellaneous Antimalarials Sales Market Share by Region (2020-2025)
 Table 19. Global Miscellaneous Antimalarials Sales by Region (2026-2031) & (Tons)
 Table 20. Global Miscellaneous Antimalarials Sales Market Share by Region (2026-2031)
 Table 21. Global Miscellaneous Antimalarials Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Miscellaneous Antimalarials Revenue Market Share by Region (2020-2025)
 Table 23. Global Miscellaneous Antimalarials Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Miscellaneous Antimalarials Revenue Market Share by Region (2026-2031)
 Table 25. North America Miscellaneous Antimalarials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Miscellaneous Antimalarials Sales by Country (2020-2025) & (Tons)
 Table 27. North America Miscellaneous Antimalarials Sales by Country (2026-2031) & (Tons)
 Table 28. North America Miscellaneous Antimalarials Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Miscellaneous Antimalarials Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Miscellaneous Antimalarials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Miscellaneous Antimalarials Sales by Country (2020-2025) & (Tons)
 Table 32. Europe Miscellaneous Antimalarials Sales by Country (2026-2031) & (Tons)
 Table 33. Europe Miscellaneous Antimalarials Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Miscellaneous Antimalarials Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Miscellaneous Antimalarials Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Miscellaneous Antimalarials Sales by Region (2020-2025) & (Tons)
 Table 37. Asia Pacific Miscellaneous Antimalarials Sales by Region (2026-2031) & (Tons)
 Table 38. Asia Pacific Miscellaneous Antimalarials Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Miscellaneous Antimalarials Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Miscellaneous Antimalarials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Miscellaneous Antimalarials Sales by Country (2020-2025) & (Tons)
 Table 42. Latin America Miscellaneous Antimalarials Sales by Country (2026-2031) & (Tons)
 Table 43. Latin America Miscellaneous Antimalarials Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Miscellaneous Antimalarials Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Miscellaneous Antimalarials Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Miscellaneous Antimalarials Sales by Country (2020-2025) & (Tons)
 Table 47. Middle East and Africa Miscellaneous Antimalarials Sales by Country (2026-2031) & (Tons)
 Table 48. Middle East and Africa Miscellaneous Antimalarials Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Miscellaneous Antimalarials Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Miscellaneous Antimalarials Sales (Tons) by Type (2020-2025)
 Table 51. Global Miscellaneous Antimalarials Sales (Tons) by Type (2026-2031)
 Table 52. Global Miscellaneous Antimalarials Sales Market Share by Type (2020-2025)
 Table 53. Global Miscellaneous Antimalarials Sales Market Share by Type (2026-2031)
 Table 54. Global Miscellaneous Antimalarials Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Miscellaneous Antimalarials Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Miscellaneous Antimalarials Revenue Market Share by Type (2020-2025)
 Table 57. Global Miscellaneous Antimalarials Revenue Market Share by Type (2026-2031)
 Table 58. Global Miscellaneous Antimalarials Price (US$/Kg) by Type (2020-2025)
 Table 59. Global Miscellaneous Antimalarials Price (US$/Kg) by Type (2026-2031)
 Table 60. Global Miscellaneous Antimalarials Sales (Tons) by Application (2020-2025)
 Table 61. Global Miscellaneous Antimalarials Sales (Tons) by Application (2026-2031)
 Table 62. Global Miscellaneous Antimalarials Sales Market Share by Application (2020-2025)
 Table 63. Global Miscellaneous Antimalarials Sales Market Share by Application (2026-2031)
 Table 64. Global Miscellaneous Antimalarials Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Miscellaneous Antimalarials Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Miscellaneous Antimalarials Revenue Market Share by Application (2020-2025)
 Table 67. Global Miscellaneous Antimalarials Revenue Market Share by Application (2026-2031)
 Table 68. Global Miscellaneous Antimalarials Price (US$/Kg) by Application (2020-2025)
 Table 69. Global Miscellaneous Antimalarials Price (US$/Kg) by Application (2026-2031)
 Table 70. Norvatis Company Information
 Table 71. Norvatis Description and Business Overview
 Table 72. Norvatis Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 73. Norvatis Miscellaneous Antimalarials Product
 Table 74. Norvatis Recent Developments/Updates
 Table 75. Teva Pharmaceutical Industries Company Information
 Table 76. Teva Pharmaceutical Industries Description and Business Overview
 Table 77. Teva Pharmaceutical Industries Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceutical Industries Miscellaneous Antimalarials Product
 Table 79. Teva Pharmaceutical Industries Recent Developments/Updates
 Table 80. Bayer AG. Company Information
 Table 81. Bayer AG. Description and Business Overview
 Table 82. Bayer AG. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 83. Bayer AG. Miscellaneous Antimalarials Product
 Table 84. Bayer AG. Recent Developments/Updates
 Table 85. GlaxoSmithKline Plc. Company Information
 Table 86. GlaxoSmithKline Plc. Description and Business Overview
 Table 87. GlaxoSmithKline Plc. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. GlaxoSmithKline Plc. Miscellaneous Antimalarials Product
 Table 89. GlaxoSmithKline Plc. Recent Developments/Updates
 Table 90. Ipca Laboratories Ltd. Company Information
 Table 91. Ipca Laboratories Ltd. Description and Business Overview
 Table 92. Ipca Laboratories Ltd. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 93. Ipca Laboratories Ltd. Miscellaneous Antimalarials Product
 Table 94. Ipca Laboratories Ltd. Recent Developments/Updates
 Table 95. Milan Pharmaceuticals Company Information
 Table 96. Milan Pharmaceuticals Description and Business Overview
 Table 97. Milan Pharmaceuticals Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 98. Milan Pharmaceuticals Miscellaneous Antimalarials Product
 Table 99. Milan Pharmaceuticals Recent Developments/Updates
 Table 100. Paso Laboratories Company Information
 Table 101. Paso Laboratories Description and Business Overview
 Table 102. Paso Laboratories Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 103. Paso Laboratories Miscellaneous Antimalarials Product
 Table 104. Paso Laboratories Recent Developments/Updates
 Table 105. Glenmark Pharmaceutical Inc. Company Information
 Table 106. Glenmark Pharmaceutical Inc. Description and Business Overview
 Table 107. Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 108. Glenmark Pharmaceutical Inc. Miscellaneous Antimalarials Product
 Table 109. Glenmark Pharmaceutical Inc. Recent Developments/Updates
 Table 110. Zydus Cadila Company Information
 Table 111. Zydus Cadila Description and Business Overview
 Table 112. Zydus Cadila Miscellaneous Antimalarials Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 113. Zydus Cadila Miscellaneous Antimalarials Product
 Table 114. Zydus Cadila Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Miscellaneous Antimalarials Distributors List
 Table 118. Miscellaneous Antimalarials Customers List
 Table 119. Miscellaneous Antimalarials Market Trends
 Table 120. Miscellaneous Antimalarials Market Drivers
 Table 121. Miscellaneous Antimalarials Market Challenges
 Table 122. Miscellaneous Antimalarials Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Miscellaneous Antimalarials
 Figure 2. Global Miscellaneous Antimalarials Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Miscellaneous Antimalarials Market Share by Type: 2024 & 2031
 Figure 4. Doxycyline Product Picture
 Figure 5. Pyrimethamine Product Picture
 Figure 6. Halofantrine Product Picture
 Figure 7. Global Miscellaneous Antimalarials Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Miscellaneous Antimalarials Market Share by Application: 2024 & 2031
 Figure 9. Prevention
 Figure 10. Treatment
 Figure 11. Global Miscellaneous Antimalarials Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Miscellaneous Antimalarials Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Miscellaneous Antimalarials Sales (2020-2031) & (Tons)
 Figure 14. Global Miscellaneous Antimalarials Average Price (US$/Kg) & (2020-2031)
 Figure 15. Miscellaneous Antimalarials Report Years Considered
 Figure 16. Miscellaneous Antimalarials Sales Share by Manufacturers in 2024
 Figure 17. Global Miscellaneous Antimalarials Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Miscellaneous Antimalarials Players: Market Share by Revenue in Miscellaneous Antimalarials in 2024
 Figure 19. Miscellaneous Antimalarials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Miscellaneous Antimalarials Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Miscellaneous Antimalarials Sales Market Share by Country (2020-2031)
 Figure 22. North America Miscellaneous Antimalarials Revenue Market Share by Country (2020-2031)
 Figure 23. U.S. Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Miscellaneous Antimalarials Sales Market Share by Country (2020-2031)
 Figure 26. Europe Miscellaneous Antimalarials Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Miscellaneous Antimalarials Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Miscellaneous Antimalarials Revenue Market Share by Region (2020-2031)
 Figure 34. China Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Taiwan Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Philippines Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Miscellaneous Antimalarials Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Miscellaneous Antimalarials Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Miscellaneous Antimalarials Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Miscellaneous Antimalarials Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Miscellaneous Antimalarials Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Miscellaneous Antimalarials by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Miscellaneous Antimalarials by Type (2020-2031)
 Figure 56. Global Miscellaneous Antimalarials Price (US$/Kg) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Miscellaneous Antimalarials by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Miscellaneous Antimalarials by Application (2020-2031)
 Figure 59. Global Miscellaneous Antimalarials Price (US$/Kg) by Application (2020-2031)
 Figure 60. Miscellaneous Antimalarials Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Malaria Prescription Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Artemisinin Antimalarial Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Specialty Pharmaceuticals Market Research Report 2024
Malaria Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anthelmintic Drugs Market Research Report 2024
Global Pyrimethamine Tablets Market Research Report 2025
Global Anti infective Drugs for Animals Market Research Report 2024
Global Animal Parasite Prevention and Control Drugs Market Research Report 2025
Global Antiparasitic Drugs for Dogs Market Research Report 2024
Global Antiparasitic Drugs for Pets Market Research Report 2025
Global Anti anemia Drugs Market Research Report 2024
Global Antiprotozoal Drugs Market Research Report 2024
Global Quinine Dihydrochloride Injection Market Research Report 2025
Chloroquine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Specialty Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Prescription Arthritis Medications Market Research Report 2024
Global Artemisinin Derivatives Market Research Report 2025
Hydroxychloroquine Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Dihydroartemisinin Market Research Report 2025
Anti worm Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions